Grifols (GRFS) EBITDA Margin Growth (1y) (2011 - 2020)
Grifols (GRFS) EBITDA Margin Growth (1y) (2011 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 22.00 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 613.00 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | -3,510.00 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | -164.00 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -370.00 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 602.00 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -16,814.00 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -611.00 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -1,961.00 |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -98.00 |
| Dec 31, 2019 | 6,358.00 |
| Mar 31, 2019 | 4,225.00 |
| Dec 31, 2018 | -1,792.00 |
| Jun 30, 2018 | -136.00 |
| Mar 31, 2018 | -134.00 |
| Dec 31, 2017 | -368.00 |
| Jun 30, 2017 | 227.00 |
| Mar 31, 2017 | 95.00 |
| Dec 31, 2016 | -8,102.00 |
| Sep 30, 2016 | -152.00 |
| Jun 30, 2016 | -68.00 |
| Mar 31, 2016 | -136.00 |
| Dec 31, 2015 | 7,818.00 |
| Sep 30, 2015 | -39.00 |
| Jun 30, 2015 | -2,667.00 |
| Mar 31, 2015 | -304.00 |
| Dec 31, 2014 | 3,120.00 |
| Sep 30, 2014 | -210.00 |
| Jun 30, 2014 | 2,260.00 |